Bio-Rad introduces the PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
New PTC Harmony thermal cycler line expands access to reliable, high‑performance PCR across academic and biopharma laboratories
New PTC Harmony thermal cycler line expands access to reliable, high‑performance PCR across academic and biopharma laboratories
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
Expanded partnership aims to advance precision oncology through distributed NGS‑based tissue and liquid biopsy testing
A study led by Karl Landsteiner University shows that the disease affects whole-brain communication networks, and that this may help predict survival
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results
Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics
New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges
In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1
Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets